What AarogyaAI does
Founded in 2019, AarogyaAI operates in Enterprise Tech industry. Initially focusing on using biotechnology and artificial intelligence to detect antibiotic resistance, the company has expanded to include machine learning in genomic diagnostics. They have launched several diagnostic platforms that integrate AI to enhance the accuracy and speed of tuberculosis testing. AarogyaAI has also broadened its technological capabilities, incorporating tools that support a wider range of infectious disease diagnostics. Competing with companies such as Innovaccer and HealthPlix.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about AarogyaAI yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.